DermTech, Inc. DMTKQ
0.00
0.00
NaN
as of 13 Aug
- Market cap
- $3.3M
- P/E
- 0.0×
Follow DMTKQ
Growth Flags
show if company had growth for consecutive years
| Mar '24 | Dec '23 | Sep '23 | Jun '23 | Older periods | |
|---|---|---|---|---|---|
| (121.75%) | (106.46%) | (96.49%) | (89.73%) |
+8 more TTM periods Free account |
|
| (64.00%) | (62.28%) | (66.29%) | (64.11%) | ||
ROIC |
(5,493.45%) | (4,806.29%) | (1,437.56%) | (3,954.90%) | |
Return on Tangible Assets |
(247.73%) | (189.31%) | (159.67%) | (142.75%) | |
Average Days of Receivables |
58.18 | 61.66 | 91.59 | 100.59 | |
Free Cash Flow per Share |
(2.08) | (2.39) | (2.62) | (2.96) | |
Free Cash Flow |
(72.07) | (77.88) | (88.50) | (94.22) | |
Capital Expenditures |
— | (0.90) | (3.00) | (2.96) | |
Piotroski F-Score |
3.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(91.22%) | (68.08%) | (60.51%) | (52.35%) | |
Accounts Receivable Turnover |
5.06 | 4.53 | 2.96 | 2.85 | |
Accounts Payable Turnover |
7.98 | 7.70 | 6.33 | 9.32 | |
Inventory Turnover |
11.92 | 10.88 | 11.51 | 10.66 | |
Average Days of Payables |
48.72 | 36.06 | 41.76 | 57.17 | |
Days of Inventory on Hand |
21.17 | 24.40 | 29.33 | 33.26 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
89.99% | 99.63% | 118.25% | 136.16% | |
Selling, General and Administrative Expense of Revenue |
507.14% | 580.39% | 663.78% | 730.24% | |
Share Based Compensation of Revenue |
105.50% | 121.37% | 143.96% | 160.11% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.80 | 0.76 | 0.78 | 0.76 | |
Depreciation/Fixed assets |
1.10 | 1.07 | 1.02 | 0.93 | |
Capex/Depreciation |
0.00 | (0.17) | (0.52) | (0.52) | |
Revenue per Share |
0.45 | 0.47 | 0.42 | 0.44 | |
Operating CF per Share |
(2.08) | (2.36) | (2.53) | (2.87) | |
Capex per Share |
0.00 | (0.03) | (0.09) | (0.09) | |
Capex to Sales |
0.00 | 0.06 | 0.21 | 0.21 | |
Net Profit Margin |
(572.19%) | (659.57%) | (765.84%) | (853.02%) |
Columns are period end dates